Kezar Life Sciences, Inc. Share Price & Technical Analysis
KZR · $7.29
Healthcare / Biotechnology
$7.29
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyos…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -3% avg return in past 3 year May month.
17% return in 2026, -54% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | 10% | 10% | -1% | 0% | – | – | – | – | – | – | – | 17% |
| 25 | -3% | -12% | -14% | -4% | -7% | 12% | -7% | -5% | 0% | 59% | 0% | 2% | 21% |
| 24 | 3% | 6% | -14% | -10% | -17% | -14% | 8% | -8% | 26% | -4% | 3% | -9% | -30% |
| 23 | 1% | -13% | -50% | -22% | 16% | -14% | -8% | -33% | -21% | -38% | 15% | 12% | -154% |
| 22 | -22% | 13% | 12% | -28% | -57% | 63% | 19% | 7% | -16% | -12% | 3% | -9% | -29% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Uptrend
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$53.86M
P/E ratio
—
52W high
$7.55
52W low
$3.53
Volume
6,16,015
Beta
0.41
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Kezar Life Sciences, Inc. share price today?
- Kezar Life Sciences, Inc. (KZR) last traded around $7.29 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KZR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KZR. Download the app for real-time alerts.
- How can I analyze Kezar Life Sciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.